Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-003509-33Phase 4Completed
Phase 4, open-label trial of Budicort in asthma (3 arms), sponsored by Copenhagen University Hospital Hvidovre, Department of Respiratory Medicine. Primary endpoint: Change in airway hyperresponsiveness per change in Na+, K+ pump content. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-003509-33.